Monitor for any subsequent filings regarding new finance leadership hires or changes in financial reporting accuracy; the consolidation of CFO and principal accounting officer roles may increase execution risk in financial oversight near-term.
Price Chart
Executive Summary
Cindy Driscoll, Senior Vice President, Finance and principal accounting officer at Climb Bio, will depart the company effective April 30, 2026, following a mutual separation agreement. Her responsibilities will be assumed by CFO Dr. Susan Altschuller, who will now serve as principal accounting officer in addition to her current role.
Key Facts
- Cindy Driscoll is departing as Senior Vice President, Finance and principal accounting officer effective April 30, 2026
- The separation was mutually agreed upon
- Dr. Susan Altschuller, current CFO, will assume the role of principal accounting officer
- No changes to Dr. Altschuller's compensation were made in connection with the appointment
- Dr. Altschuller has extensive financial leadership experience at biotech firms including Cerevel Therapeutics, ImmunoGen, and Alexion Pharmaceuticals
Financial Impact
No immediate financial impact disclosed; no compensation changes for CFO
Risk Factors
- Increased workload for CFO could impact financial reporting quality
- Potential for additional departures if part of broader restructuring
- Governance risk from concentration of financial leadership roles
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001193125-26-142114 |
| Document: 0001193125-26-142114-index-headers.html | 0001193125-26-142114 |
| Document: 0001193125-26-142114-index.html | 0001193125-26-142114 |
| Document: 0001193125-26-142114.txt | 0001193125-26-142114 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | — | awaiting T+1 | — | — |
Oct 23, 2026 3d ago | 8-K | $10.47 | awaiting T+1 | — | $10.19 (−2.67%) |
Oct 23, 2026 3d ago | Press Release | $10.34 | awaiting T+1 | — | $10.19 (−1.45%) |
Sep 22, 2026 4w ago | Institutional Cluster | $14.21 $12.52 | ▼ −11.89% | ▼ −11.17% | $10.19 (−28.29%) |
Sep 3, 2026 7w ago | 8-K | $14.59 $15.52 | ▲ +6.37% | ▲ +6.76% | $10.19 (−30.16%) |
Aug 14, 2026 10w ago | 8-K | $16.33 $17.44 | ▲ +6.80% | ▲ +7.27% | $10.19 (−37.60%) |
Aug 6, 2026 11w ago | 8-K | $14.00 $14.00 | · 0.00% | ▼ −0.61% | $10.19 (−27.21%) |
Jun 30, 2026 16w ago | 144 | $13.29 $12.90 | ▼ −2.93% | ▼ −2.80% | $10.19 (−23.33%) |
Jun 12, 2026 19w ago | 8-K | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $10.19 (+11.31%) |
Jun 12, 2026 19w ago | 424B5 | $11.49 $10.71 | ▲ +6.79% | ▲ +6.19% | $10.19 (+11.31%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers